RNA Formulation Resources
-
Exploring Osmolality As A CQA Within RNA Therapeutics
10/3/2023
Discover how osmolality can be applied throughout the bioprocessing workflow for RNA, and recognize the importance of this sensitive measurement, from formulation optimization to cryopreservation techniques.
-
Developing An mRNA-Encoded Antibody Platform To Accelerate Therapies To Clinic
11/20/2024
In this paper, we present the foundation of an mRNA-LNP platform for encoding and expressing therapeutic antibodies in vivo, eliminating the need for costly and time-consuming manufacturing.
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
8/15/2024
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
Co-Precipitation Of Metal Carbonate Templated Protein Microparticles
12/9/2024
Explore the automated production of protein microparticles using an innovative method that offers a standardized and scalable solution for co-precipitation in biopolymer particle fabrication.
-
Drug Discovery And Screening, A Digital Era For RNA-LNP Therapeutics
11/21/2022
Learn about the key stages of drug discovery and screening as well as how to overcome bottlenecks in screening mRNA-LNPs to rapidly develop genomic medicines.
-
Delivering The Promise Of Gene Therapy
1/22/2024
Gene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.
-
Fit-For-Purpose Lipids Can Accelerate, Scale, And Improve RNA-LNP Drugs
6/22/2023
Emerging biotech companies are investing in novel delivery capabilities to address different modalities' needs and extra-hepatic delivery. Explore steps to accelerate commercial nanomedicine delivery.
-
High-Throughput Platform Propels Gene Editing Therapy Research
3/1/2024
Explore the potential of polymeric nanoparticles (PNPs) as an alternative to viral vectors. PNPs offer design flexibility, enabling larger payloads, targeted release, and minimized side effects.
-
Hemophilia - Global Clinical Trial Landscape
11/7/2023
Delve into the clinical landscape of hemophilia, a rare X-linked congenital bleeding disorder, across three key regions of the globe, namely Asia Pacific, Europe, and North America.
-
mRNA Manufacturing And Formulation
11/15/2022
From fermentation to formulation, mRNA manufacturing requires a toolbox of technologies, services, and expertise. Explore our portfolio of solutions for making, purifying, and formulating mRNA.